Indian AI Tool for Cancer Care Spotlighted in BRICS Health Journal
iOncology.ai, a cancer care AI platform by AIIMS and C-DAC, gains global attention at the BRICS Summit.
An Indian-developed artificial intelligence platform for cancer care, iOncology.ai, is receiving international recognition after being featured in a special issue of the BRICS Health Journal. The platform, created by the All India Institute of Medical Sciences (AIIMS) in New Delhi and the Centre for Development of Advanced Computing (C-DAC) in Pune, was highlighted during the BRICS Summit held from September 12-13.
AI-Driven Innovation in Cancer Care
iOncology.ai is designed to streamline the integration of cancer-related clinical data, enhancing early detection, risk assessment, treatment planning, multidisciplinary review, and longitudinal patient-data management. This initiative has been supported by the Ministry of Electronics and Information Technology, reflecting India’s commitment to leveraging technology in healthcare.
A review titled “Transforming Cancer Care in Emerging Economies: India’s AI Innovation,” authored by Ashok Sharma and colleagues from AIIMS and C-DAC, explores how AI can enhance cancer screening and diagnosis, particularly in emerging economies. According to Dr. Sharma, the platform aims to reduce cancer-care disparities across the Global South by providing evidence-based, interoperable solutions tailored to specific regional needs.
Clinical Validation and Future Prospects
Currently, iOncology.ai is in the pilot stage of clinical validation and implementation evaluation. This phase is crucial for assessing the platform’s performance and potential integration into clinical settings. Despite the promising outlook, the platform has yet to undergo peer-reviewed validation to confirm its diagnostic accuracy and clinical utility. Prospective multicenter validation studies are planned to ensure its efficacy before broader clinical adoption.
The review underscores the significant need for improved cancer care solutions in BRICS countries, which account for over 40% of the global population and report approximately 9 million new cancer cases annually. The platform is seen as a potential game-changer in these regions, where access to screening and specialist care often varies widely.
Integration with India’s Health Infrastructure
iOncology.ai is poised to become an integral part of India’s expanding digital health ecosystem, which includes initiatives like population screening, cancer surveillance, and the Ayushman Bharat Digital Mission. The platform utilizes curated Indian clinical, radiological, and histopathological datasets, with plans to incorporate genetic data and collaborate with electronic health record systems.
Through collaborations facilitated by the BRICS Summit, the developers hope to foster advancements in cancer prevention, early diagnosis, and treatment, particularly in resource-constrained settings. The ultimate goal is to empower clinicians and provide more equitable cancer care solutions.